Description: Trajan Group Holdings Limited develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including syringes, GC columns and septa, rings, inlet liners, and tubing products; pathology products, consisting of NBF containers, adhesive and frosted microscope slides, coverslips, slide storage trays/mailers, cassette storage boxes, biopsy pads, histology wax plus, microtome blades, and marking dyes and sets, and MiPlatform, a smartphone adapter. It also provides sampling products, comprising septa, caps, liners, crimping tools, well plates and sealing mats, and micro sampling tools, as well as automation systems for the analysis of biological, food, and environmental samples. The company was incorporated in 2011 and is headquartered in Ringwood, Australia.
Home Page: www.trajanscimed.com
7 Argent Place
Ringwood,
VIC
3134
Australia
Phone:
61 3 9837 4200
Officers
| Name | Title |
|---|---|
| Mr. Stephen Tomisich | Founder, CEO, MD & Executive Director |
| Mr. Alister John Hodges CPA, CPA | CFO & Company Secretary |
| Mr. Nigel Gilligan | Chief Operations Officer |
| Dr. Andrew Arthur Gooley | Chief Scientific Officer |
| Mr. Robert Lyon | Executive Director, Head of Corporate Development & General Counsel |
| Mr. Sam Evans | Senior Vice President of Customer Relationships |
| Ms. Rebecca Jayne Wilson B.A. | Investor Relations Advisor |
| Marie Krstic | Chief Marketing Officer |
| Ms. Helene Lajoie | Chief Human Resources Officer |
| Mr. Mark Andrew Licciardo B Bus (Acc), FCIS, FGIA, GAICD, GradDip CSP | Joint Company Secretary |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 140.8451 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.4611 |
| Price-to-Sales TTM: | 0.6356 |
| IPO Date: | |
| Fiscal Year End: | June |
| Full Time Employees: | 600 |